Stocks · Korea 016580 KOSPI

Whanin Pharm

10,180원 -0.10% Market cap 1,893억 2026-10-07 close
Data as of 2026-10-07 · Linked from 7 pages
An overview for this page is not available in English yet. The figures below are updated daily.

Key figures 2026-10-07 basis

PER11.88x
PBR0.45x
EPS857 KRW
BPS22,777 KRW
ROE3.76%
DPS300 KRW

Returns and 52-week range

1W+1.29%
1M-2.02%
3M+4.09%
6M-3.32%
1Y-9.27%
YTD-6.26%
52W high12,140원
52W low9,160원
From 52W high-16.14%

Financial results (consolidated)

PeriodRevenueOperating incomeNet incomeOP margin
20221,989억298억237억15.0%
20232,304억302억298억13.1%
20242,596억215억234억8.3%
20252,552억130억136억5.1%
Quarterly
2024 4Q663억9억36억1.4%
2025 1Q602억53억51억8.8%
2025 2Q641억27억32억4.2%
2025 3Q657억36억33억5.4%
2025 4Q651억15억20억2.3%
2026 1Q712억94억75억13.2%

Company

CEO이광식, 이원범(각자 대표이사)
Founded1982-12-16
Fiscal year end12
Address: 서울특별시 송파구 법원로6길 11 (문정동, 환인빌딩)

Peers in the same sector

CompanyMarket capP/EP/B1M
이연제약1,903억—0.85+3.33%
종근당홀딩스1,881억4.420.28-3.47%
한국유니온제약1,924억——+0.00%
삼일제약1,850억—1.36+40.30%
코오롱생명과학1,930억7.370.33+1.17%
대원제약1,850억—0.66+3.25%

Recent filings

Source: DART (Financial Supervisory Service electronic disclosure)

Sources and notes

This page summarizes public filings, market data and news for information only. It is not a recommendation to buy or sell any security. Figures are as of the dates shown; check the original filings before making decisions.